Table 1 Clinical and pathological data of Cases and Controls
From: Analysis of lncRNA sequences: FAM3D-AS1, LINC01230, LINC01315 and LINC01468 in endometrial cancer
Cases | Controls | |
|---|---|---|
Median age (range) | 61,2 (47–85) | 53,2 (48–84) |
Body mass index (BMI) (kg/m2) | ||
< 24,9 (normal) | 27 (22,5%) | 29 (36,25%) |
25–29,9 (overweight) | 31 (25,8%) | 28 (35%) |
> 30 (obese) | 62 (51,67%) | 23 (28,75%) |
Parity | ||
1 | 41 (34,17%) | 22 (27,5%) |
2 to 3 | 48 (40%) | 44 (55%) |
> 4 | 31 (25,83%) | 14 (17,5%) |
Use of hormone replacement therapy (HRT) | ||
Yes | 23 (19,17%) | 14 (17,5%) |
No | 97 (80,83%) | 66 (82,5%) |
Grading | ||
G1 | 44 (36,67%) | n/a |
G2 | 58 (48,33%) | |
G3 | 18 (15%) | |
Staging (FIGO) | n/a | |
IA | 71 (59,17%) | |
IB | 29 (24,17%) | |
II | 1 (0,83%) | |
IIIA | 5 (4,17%) | |
IIIB | 4 (3,33%) | |
IIIC1 | 10 (8,33%) | |